Background

Mr. Vaughn D. Bryson serves as the President of ExtendBar which he founded in 1999. Mr. Bryson worked for 32 years at Eli Lilly and Company and served as the President and Chief Executive Officer of Eli Lilly from 1991 to 1993. He served as an Executive Vice President from 1986 until 1991 and served as a Director from 1984 until his retirement in 1993. He served on the board of directors of Eli Lilly. Mr. Bryson served as the President of Life Science Advisors LLC, from ... May 1995 to 2004. Mr. Bryson has served as a Director of Atherogenics Inc., since February 2000 until September 18, 2008 and served in a consulting role from February 2000 until February 2004. He serves as also a Member of Advisory Board at Polaris Venture Partners, Inc and Mountain Group Capital LLC. He has been Director at National Wine & Spirits, Inc., since July 1999, Pharmaceutical Product Development, LLC since May 18, 2011 and EndoVascular Technologies, Inc., since May 1994. He serves as a Director at ICOS Corporation and Clinical Products, LLC. He served as a Director of Chiron, Corp. since June 1997, Elan Corporation, plc., since July 16, 2009, Perclose, Inc., since July 1995, and Quintiles Transnational Corp., since March 1997. He served as Independent Director at Amylin Pharmaceuticals, Inc., from July 1999 to May 23, 2007 and its Lead Director until May 23, 2007. He served as Director of Ariad Pharmaceuticals, Fusion Medical Technologies, Inc., Tapestry Pharmaceuticals (NaPro Biotherapeutics), and Applied NeuroSolutions Inc. (Molecular Geriatrics Corporation). Mr. Bryson served as Vice Chairman of Vector Securities International, LLC from April 1994 to December 1996. HE has over 40 years of experience as an executive, a Director and Advisor in the healthcare industry. Mr. Bryson received a B.S. degree in Pharmacy from the University of North Carolina in 1960 and completed the Sloan Program at the Stanford University Graduate School of Business in 1967.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.